BeStock  

Castle Biosciences CSTL

US equityMarket cap rank #3147Diagnostics & Research
$32.86 −$0.55 (-1.63%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $32.86 0.00%
Open$32.76
Prev close$33.41
Day range$32.54 – $33.38
Volume309.2K
Market cap$1.01B
P/E (TTM)–
Dividend yield–

CSTL Stock News

Headlines matching Castle Biosciences or the CSTL ticker, most recent first.

  • Roth MKM Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $50 PositiveMarket news · 22 Sep 2026 · Direct mention
  • CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $40Market news · 3 Aug 2026 · Direct mention
  • BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $44 PositiveMarket news · 3 Aug 2026 · Direct mention
  • Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $36 NegativeMarket news · 31 Jul 2026 · Direct mention
  • Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $57 PositiveMarket news · 31 Jul 2026 · Direct mention
  • Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $52Market news · 7 May 2026 · Direct mention
  • Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $43 NegativeMarket news · 7 May 2026 · Direct mention
  • Guggenheim Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $47Market news · 7 May 2026 · Direct mention
  • KeyBanc Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $35 NegativeMarket news · 29 May 2026 · Direct mention
  • BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $40Market news · 13 May 2026 · Direct mention
  • BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $40 NegativeMarket news · 13 May 2026 · Direct mention
  • CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $40 NegativeMarket news · 20 Apr 2026 · Direct mention
  • CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $50Market news · 3 Mar 2026 · Direct mention
  • Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $44 PositiveMarket news · 27 Feb 2026 · Direct mention
  • A Quick Look at Today's Ratings for Castle Biosciences(CSTL.US), With a Forecast Between $39 to $50Market news · 7 Nov 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on CSTL.

Sign in to join the discussion.

Scroll to Top